Search

everythinglearnresearchcommunity

for

Search:↓

Future hair loss treatments should aim to extend hair growth, reactivate resting follicles, reverse shrinkage, and possibly create new follicles, with gene therapy showing promise.

Visible light can damage skin and most sunscreens don't block it well; more research is needed on its effects and protection methods.

Experts recommend thorough medical, sexual, and psychosocial assessments for women's sexual dysfunctions, and suggest individualized treatment plans with regular check-ups. They also mention potential use of estrogen and androgen therapy, but with caution due to safety concerns.

Hair follicle stem cells are key for hair and skin regeneration, can be reprogrammed, and have potential therapeutic uses, but also carry a risk of cancer.

Lichen planus is a skin condition that can resolve on its own, is linked to hepatitis C, and increases the risk of skin cancer.

Effective treatments for male pattern baldness include oral finasteride and topical minoxidil, while topical minoxidil is best for female pattern baldness.

Alopecia areata causes hair loss, has no cure, and various treatments exist.

The dermal papilla is crucial for hair growth and health, and understanding it could lead to new hair loss treatments.

Understanding how cells die in the skin is important for treating skin diseases and preventing hair loss.

Hair loss in men treated best with early medication or transplant, new treatments researched.

The Lexington LaserComb helped regrow hair in mice with a condition similar to human hair loss.

Androgenetic alopecia involves genetics, hormones, and can be treated with medications or surgery.

Nonionic liposomes are the best for delivering genes to skin cells.

European guidelines recommend regular eye and ear exams, skin care, vitamin D supplements, and cautious use of medications for managing congenital ichthyoses.

Male pattern hair loss caused by follicular miniaturization; early diagnosis and treatment can reduce psychological burden.

Research on epidermal stem cells has advanced significantly, showing promise for improved clinical therapies.

Hair follicles offer promising targets for delivering drugs to treat hair and skin conditions.

LGBT individuals have unique skin health needs, including higher STD risks and side effects from gender-affirming treatments, requiring dermatologists to offer knowledgeable and culturally competent care.

Female pattern hair loss diagnosed by scalp appearance, treated with combined therapies and targeted approaches.

A new wearable LED device helps heal chronic infected wounds at home.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

Microencapsulation helps protect and track therapeutic cells, showing promise for treating various diseases, but more work is needed to improve the technology.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Optimized film improves finasteride skin absorption and treatment efficiency.

The document concludes that accurate diagnosis and treatment of scalp itch require differentiating between various conditions using a proposed five-step evaluation process.

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

Hair dyes can change hair color temporarily or permanently but may cause side effects like skin reactions and hair damage.

The conclusion is that skin and hair patterns are formed by a mix of cell activities, molecular signals, and environmental factors.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.